Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.03 by 100 percent. This is a 20 percent increase over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $138.964 million which beat the analyst consensus estimate of $133.233 million by 4.30 percent. This is a 15.04 percent increase over sales of $120.794 million the same period last year.